These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Drug efflux and lipid A modification by 4-L-aminoarabinose are key mechanisms of polymyxin B resistance in the sepsis pathogen Enterobacter bugandensis. García-Romero I; Srivastava M; Monjarás-Feria J; Korankye SO; MacDonald L; Scott NE; Valvano MA J Glob Antimicrob Resist; 2024 Jun; 37():108-121. PubMed ID: 38552872 [TBL] [Abstract][Full Text] [Related]
3. Cefiderocol susceptibility of Achromobacter spp.: study of an accurately identified collection of 230 strains. Jean-Pierre V; Sorlin P; Pantel A; Chiron R; Lavigne JP; Jeannot K; Marchandin H; Ann Clin Microbiol Antimicrob; 2024 Jun; 23(1):54. PubMed ID: 38886694 [TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of Burkholderia vietnamiensis to aminoglycosides. Jassem AN; Zlosnik JE; Henry DA; Hancock RE; Ernst RK; Speert DP Antimicrob Agents Chemother; 2011 May; 55(5):2256-64. PubMed ID: 21321142 [TBL] [Abstract][Full Text] [Related]
5. Polymyxin B Pharmacodynamics in the Hollow-Fiber Infection Model: What You See May Not Be What You Get. Maynard M; Drusano GL; Vicchiarelli M; Liu W; Myrick J; Nole J; Duncanson B; Brown D; Louie A Antimicrob Agents Chemother; 2021 Jul; 65(8):e0185320. PubMed ID: 34097487 [TBL] [Abstract][Full Text] [Related]
6. Potent activity of polymyxin B is associated with long-lived super-stoichiometric accumulation mediated by weak-affinity binding to lipid A. Buchholz KR; Reichelt M; Johnson MC; Robinson SJ; Smith PA; Rutherford ST; Quinn JG Nat Commun; 2024 Jun; 15(1):4733. PubMed ID: 38830951 [TBL] [Abstract][Full Text] [Related]
7. A novel major facilitator superfamily-type tripartite efflux system CprABC mediates resistance to polymyxins in Zhang L; Wang M; Qi R; Yang Y; Liu Y; Ren N; Feng Z; Liu Q; Cao G; Zong G Front Microbiol; 2024; 15():1346340. PubMed ID: 38596380 [TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes associated with polymyxin B dose in patients with bloodstream infections due to carbapenem-resistant Gram-negative rods. Nelson BC; Eiras DP; Gomez-Simmonds A; Loo AS; Satlin MJ; Jenkins SG; Whittier S; Calfee DP; Furuya EY; Kubin CJ Antimicrob Agents Chemother; 2015 Nov; 59(11):7000-6. PubMed ID: 26324272 [TBL] [Abstract][Full Text] [Related]
9. The QseB response regulator imparts tolerance to positively charged antibiotics by controlling metabolism and minor changes to LPS. Hurst MN; Beebout CJ; Hollingsworth A; Guckes KR; Purcell A; Bermudez TA; Williams D; Reasoner SA; Trent MS; Hadjifrangiskou M mSphere; 2023 Oct; 8(5):e0005923. PubMed ID: 37676915 [TBL] [Abstract][Full Text] [Related]
10. Electrochemical and Infrared Studies of a Model Bilayer of the Outer Membrane of Gram-Negative Bacteria and its Interaction with polymyxin─the Last-Resort Antibiotic. Su Z; Chen A; Lipkowski J Langmuir; 2024 Apr; 40(15):8248-8259. PubMed ID: 38578277 [TBL] [Abstract][Full Text] [Related]
11. A Sensitive GC-MS Method for Quantitation of Lipid A Backbone Components and Terminal Phosphate Modifications. Sherman ME; Smith RD; Gardner FM; Goodlett DR; Ernst RK J Am Soc Mass Spectrom; 2022 Dec; 33(12):2301-2309. PubMed ID: 36326685 [TBL] [Abstract][Full Text] [Related]
12. Outcome of intravenous and inhaled polymyxin B treatment in patients with multidrug-resistant gram-negative bacterial pneumonia. Ding P; Li H; Nan Y; Liu C; Wang G; Cai H; Yu W Int J Antimicrob Agents; 2024 Aug; 64(4):107293. PubMed ID: 39094752 [TBL] [Abstract][Full Text] [Related]
13. Reaction-Induced Self-Assembly of Polymyxin Mitigates Cytotoxicity and Reverses Drug Resistance. Hu X; Li D; Li H; Piao Y; Wan H; Zhou T; Karimi M; Zhao X; Li Y; Shi L; Liu Y Adv Mater; 2024 Jul; ():e2406156. PubMed ID: 39022883 [TBL] [Abstract][Full Text] [Related]
14. Discovery, Characterization, and Bioactivity of the Achromonodins: Lasso Peptides Encoded by Carson DV; Zhang Y; So L; Cheung-Lee WL; Cartagena AJ; Darst SA; Link AJ J Nat Prod; 2023 Nov; 86(11):2448-2456. PubMed ID: 37870195 [TBL] [Abstract][Full Text] [Related]
15. Differences in Gene Expression Profiles between Early and Late Isolates in Monospecies Achromobacter Biofilm. Nielsen SM; Meyer RL; Nørskov-Lauritsen N Pathogens; 2017 May; 6(2):. PubMed ID: 28534862 [TBL] [Abstract][Full Text] [Related]
16. Genetic Basis and Physiological Effects of Lipid A Hydroxylation in Lo Sciuto A; Cervoni M; Stefanelli R; Spinnato MC; Di Giamberardino A; Mancone C; Imperi F Pathogens; 2019 Dec; 8(4):. PubMed ID: 31835493 [TBL] [Abstract][Full Text] [Related]
17. Increasing outer membrane complexity: the case of the lipopolysaccharide lipid A from marine Cellulophaga pacifica. Andretta E; De Chiara S; Pagliuca C; Cirella R; Scaglione E; Di Rosario M; Kokoulin MS; Nedashkovskaya OI; Silipo A; Salvatore P; Molinaro A; Di Lorenzo F Glycoconj J; 2024 Apr; 41(2):119-131. PubMed ID: 38642279 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumannii. Kon H; Hameir A; Nutman A; Temkin E; Keren Paz A; Lellouche J; Schwartz D; Weiss DS; Kaye KS; Daikos GL; Skiada A; Durante-Mangoni E; Dishon Benattar Y; Yahav D; Daitch V; Bernardo M; Iossa D; Friberg LE; Theuretzbacher U; Leibovici L; Dickstein Y; Pollak D; Mendelsohn S; Paul M; Carmeli Y Microbiol Spectr; 2023 Jun; 11(3):e0509322. PubMed ID: 37219426 [TBL] [Abstract][Full Text] [Related]
19. Polymyxin Resistance and Heteroresistance Are Common in Clinical Isolates of MacDonald L; Keenan S; Di Lorenzo F; Adade NE; Kenna DTD; Millar BC; Moore JE; Ramos Vivas J; Molinaro A; Valvano MA Microbiol Spectr; 2023 Feb; 11(1):e0372922. PubMed ID: 36519943 [TBL] [Abstract][Full Text] [Related]